MPHASIS LIMITED (526299) — Latest Corporate Announcements
₹2,453.3
+₹99.80 (+4.24%)
Market Cap
₹46,826.29 Cr
P/E Ratio
24.47
52W Range
₹2013 – ₹2975
Board Meeting Intimations
📅 Scheduled Board Meeting & Agenda
Meeting Date: 05-Nov-2026
Agenda / Purpose: Financial Results
Timeline: In 23 days
Corporate Actions & Regulatory Filings
To consider and approve the financial results for the period ended September 30, 2026
Mphasis Ltd - 526299 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
MphasiS Limited has informed the Exchange regarding Grant of 107578 Options.
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Mphasis Ltd - 526299 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Mphasis Ltd - 526299 - Board Meeting Intimation for Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026.
Mphasis Ltd - 526299 - Closure of Trading Window
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mphasis Ltd - 526299 - Intimation Of ESG Rating By NSE Sustainability Ratings And Analytics Limited
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Mphasis Ltd - 526299 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
To consider and approve the financial results for the period ended June 30, 2026.
Financial Results (Quarterly & Annual)
| Quarter / Period | Meeting / Outcome Date | Status | Filing Details |
|---|---|---|---|
| Quarter Ended 30-Sep-2026 (Q2 FY27) | 05-Nov-2026 | Scheduled Upcoming | To consider and approve the financial results for the period ended September 30, 2026 |
| Quarter Ended 30-Jun-2026 (Q1 FY27) | 23-Jul-2026 | Declared | To consider and approve the financial results for the period ended June 30, 2026. |
| Year Ended 31-Mar-2026 (Q4 FY26) | 29-Apr-2026 | Declared | To consider and approve the financial results for the quarter and year ended March 31, 2026, along with the Auditor s Report thereon, the recommendation of dividend, if any, among other matters. |
| Quarter Ended 31-Dec-2025 (Q3 FY26) | 22-Jan-2026 | Declared | To consider and approve the financial results for the period ended December 31, 2025 |
| Quarter Ended 30-Sep-2025 (Q2 FY26) | 30-Oct-2025 | Declared | To consider and approve the financial results for the period ended September 30, 2025 |
| Quarter Ended 30-Jun-2025 (Q1 FY26) | 24-Jul-2025 | Declared | To consider and approve the financial results for the period ended Jun 30, 2025 |
| Year Ended 31-Mar-2025 (Q4 FY25) | 24-Apr-2025 | Declared | To consider and approve the financial results for the period ended March 31, 2025 and dividend, if any |
| Quarter Ended 31-Dec-2024 (Q3 FY25) | 23-Jan-2025 | Declared | To consider and approve the financial results for the period ended December 31, 2024 |
| Quarter Ended 30-Sep-2024 (Q2 FY25) | 16-Oct-2024 | Declared | The Company has informed further to intimation dated 20 September 2024, regarding the Board Meeting, which was scheduled to be held over Tuesday, 15 October 2024 and Wednesday, 16 October 2024, we wish to inform you that the meeting of Board of Directors of the Company is now being scheduled on Wednesday, 16 October 2024 at New York, USA, inter-alia, to consider and approve the audited financial results of Mphasis Limited and Group, for the quarter and the half year ending 30 September 2024. |
| Quarter Ended 30-Jun-2024 (Q1 FY25) | 25-Jul-2024 | Declared | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Year Ended 31-Mar-2024 (Q4 FY24) | 25-Apr-2024 | Declared | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Quarter Ended 31-Dec-2023 (Q3 FY24) | 01-Feb-2024 | Declared | To consider and approve the financial results for the period ended December 31, 2023 |
Track Related Peer Equities
Related Research Guides & Regulatory Playbooks
Frequently Asked Questions about MPHASIS LIMITED BSE Disclosures
What is the latest BSE announcement by MPHASIS LIMITED?
The latest BSE disclosure by MPHASIS LIMITED (MPHASIS), filed on 05-Nov-2026 , is: "To consider and approve the financial results for the period ended September 30, 2026". Bsenexus tracks every official filing for MPHASIS LIMITED with AI-powered summaries on its announcements feed.
When is MPHASIS LIMITED's next board meeting?
MPHASIS LIMITED has a board meeting scheduled for 05-Nov-2026 (in 23 days) to consider: Financial Results.
When does MPHASIS LIMITED declare quarterly results?
Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. MPHASIS LIMITED's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.